NEWS
Mesoblast surges on FDA nod for its cell therapy

MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per ... read more
MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per ... read more